潜在危险：新出现的证据。
Lurking Danger: Emerging Evidence.
作者信息
Gopal Palepu B
机构信息
Department of Critical Care Medicine, Citizens Specialty Hospital, Hyderabad, Telangana, India.
出版信息
Indian J Crit Care Med. 2024 Feb;28(2):93-94. doi: 10.5005/jp-journals-10071-24644.
Abstract
Gopal PB. Lurking Danger: Emerging Evidence. Indian J Crit Care Med 2024;28(2):93-94.
摘要
戈帕尔·PB。潜在危险：新出现的证据。《印度重症监护医学杂志》2024年；28(2)：93 - 94。
相似文献
1
Lurking Danger: Emerging Evidence.潜在危险：新出现的证据。
Indian J Crit Care Med. 2024 Feb;28(2):93-94. doi: 10.5005/jp-journals-10071-24644.
2
Fecal Microbiota Transplantation for -associated Diarrhea in Hematopoietic Stem Cell Transplant Recipients: A Single-center Experience from a Tertiary Center in India.粪便微生物群移植治疗造血干细胞移植受者的相关性腹泻：印度一家三级中心的单中心经验。
Indian J Crit Care Med. 2024 Feb;28(2):106-110. doi: 10.5005/jp-journals-10071-24607.
3
and Antibiotic-associated Diarrhea.以及抗生素相关性腹泻。
Indian J Crit Care Med. 2020 Sep;24(Suppl 4):S162-S167. doi: 10.5005/jp-journals-10071-23619.
4
The Clasp of CLABSI.中心静脉导管相关血流感染的关键因素
Indian J Crit Care Med. 2020 Jan;24(1):3-5. doi: 10.5005/jp-journals-10071-23335.
5
Secondary Hemophagocytic Lymphohistiocytosis: Think of the Devil Lurking!继发性噬血细胞性淋巴组织细胞增生症：警惕隐藏的“恶魔”！
Indian J Crit Care Med. 2022 May;26(5):545-546. doi: 10.5005/jp-journals-10071-24216.
6
Time to Place Infections in Major Healthcare-associated Infections List.将感染列入主要医疗保健相关感染清单的时间。
Indian J Crit Care Med. 2023 Feb;27(2):152-153. doi: 10.5005/jp-journals-10071-24403.
7
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.造血干细胞移植受者复发性艰难梭菌感染的粪便微生物群移植
Transpl Infect Dis. 2016 Aug;18(4):628-33. doi: 10.1111/tid.12550. Epub 2016 Jul 5.
8
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.粪菌移植治疗艰难梭菌感染：一项系统评价
J Clin Gastroenterol. 2014 Sep;48(8):693-702. doi: 10.1097/MCG.0000000000000046.
9
[Refractory colitis by Clostridium difficile treated with fecal microbiota transplant].[艰难梭菌所致难治性结肠炎经粪便微生物群移植治疗]
Medicina (B Aires). 2019;79(4):291-294.
10
Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report.粪菌移植治愈患有庞贝病儿童的艰难梭菌感染：一例报告
J Med Case Rep. 2018 Apr 28;12(1):112. doi: 10.1186/s13256-018-1659-2.
本文引用的文献
1
Fecal Microbiota Transplantation for -associated Diarrhea in Hematopoietic Stem Cell Transplant Recipients: A Single-center Experience from a Tertiary Center in India.粪便微生物群移植治疗造血干细胞移植受者的相关性腹泻：印度一家三级中心的单中心经验。
Indian J Crit Care Med. 2024 Feb;28(2):106-110. doi: 10.5005/jp-journals-10071-24607.
2
Regulation, risk and safety of Faecal Microbiota Transplant.粪便微生物群移植的监管、风险与安全性
Infect Prev Pract. 2020 Sep;2(3):100069. doi: 10.1016/j.infpip.2020.100069. Epub 2020 Jun 9.
3
Cost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review.粪便微生物群移植治疗复发性艰难梭菌感染的成本效益：一项文献综述
Cureus. 2017 Aug 23;9(8):e1599. doi: 10.7759/cureus.1599.
4
Faecal microbiota transplantation for <em>Clostridium difficile</em>-associated diarrhoea: a systematic review of randomised controlled trials.粪便微生物群移植治疗艰难梭菌相关性腹泻：随机对照试验的系统评价。
Med J Aust. 2017 Aug 21;207(4):166-172. doi: 10.5694/mja17.00295.
5
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.系统评价与荟萃分析：粪便微生物群移植治疗复发性和难治性艰难梭菌感染的疗效
Aliment Pharmacol Ther. 2017 Sep;46(5):479-493. doi: 10.1111/apt.14201. Epub 2017 Jul 14.
6
Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives.粪便微生物群移植：当前应用、有效性及未来展望
Clin Endosc. 2016 May;49(3):257-65. doi: 10.5946/ce.2015.117. Epub 2016 Mar 9.
7
Duodenal infusion of donor feces for recurrent Clostridium difficile.经十二指肠输注供体粪便治疗复发性艰难梭菌感染。
N Engl J Med. 2013 Jan 31;368(5):407-15. doi: 10.1056/NEJMoa1205037. Epub 2013 Jan 16.
8
Clostridium difficile infection: new insights into management.艰难梭菌感染：管理的新见解。
Mayo Clin Proc. 2012 Nov;87(11):1106-17. doi: 10.1016/j.mayocp.2012.07.016.
9
Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report.癌症或造血干细胞移植患者中医院获得性艰难梭菌感染率：C3IC 网络报告。
Infect Control Hosp Epidemiol. 2012 Nov;33(11):1162-5. doi: 10.1086/668023. Epub 2012 Sep 24.
10
Gut microbiota: married to our gut microbiota.肠道微生物群：与我们的肠道微生物群紧密相连。
Nat Rev Gastroenterol Hepatol. 2012 Oct;9(10):555. doi: 10.1038/nrgastro.2012.165.
Zotero 插件